Body Vision Medical Raises New Funding for Lung Imaging Expansion
Aug 06, 2026
Funding
MaxQ Medical Raises $31.5 Million for Prostate Care Platform
August 20, 2026
MaxQ Medical raised $31.5 million in Series A funding to grow its team and advance clinical work on a transurethral imaging and therapy system for prostate care.
MaxQ Medical has closed a $31.5 million Series A financing to advance its prostate care platform, the company announced in a press release. The round was led by Atlantic Blue Ventures, S3 Ventures, and Olympus Innovation Ventures, with participation from existing investor Hillside Capital.
The company said the funds will be used to expand its team and move forward with its clinical program. MaxQ Medical is developing a transurethral system that combines advanced imaging with therapy in one procedure for prostate care.
The first planned indication is benign prostatic hyperplasia. MaxQ Medical also plans to expand the platform into focal therapy for prostate cancer and later into prostate diagnostics, including biopsy and tumor mapping.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Funding
08/20
Pixelgen Raises $15.5 Million for Proxiome Kit Expansion
08/20
Math Magic Raises Nearly $50 Million for AI 3D Creation Platform
08/20
Curve Dental Plans $200 Million Investment in Curve Hero
08/19
CATL and Quinbrook Start Supernode Phase 2 Operations and Secure Phase 3 Financing
08/19
WhiteFiber Plans $250 Million Notes Offering for AI Data Centers
More from: Life Sciences
08/20
Curitics Health Adds AI Tools for Clinical Workflows
08/20
Pixelgen Raises $15.5 Million for Proxiome Kit Expansion
08/20
Mednet Launches TrialMatch for Cancer Clinical Trial Discovery
08/20
Matwings Supports GenSci148 Protein Program Cleared for China Clinical Trial
08/20
Benchling Adds Chemistry Tools and Inductive Bio Models to R&D Platform
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation
The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.
Read more